[Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin]. 1985

L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu

The minimal inhibitory concentrations of three antimicrobial agents were determined by two fold dilution in Wilkins Chalgren agar for over 569 anaerobes isolated and collected from 20 French hospitals. Metronidazole, cefoxitin and clindamycin inhibited respectively 95, 97 and 91% of tested strains. No metronidazole resistant strains could be found among Bacteroides fragilis group, Fusobacterium and Clostridium other than C. perfringens. Cefoxitin was the most active against C. perfringens, Gram positive cocci and non sporulated bacilli. Clindamycin resistance was observed mainly with B. fragilis and Clostridium other than C perfringens. This phenomenon occurred in most hospitals where strains were isolated.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D001421 Bacteria, Anaerobic Bacteria that can survive and grow in the complete, or nearly complete absence of oxygen. Anaerobic Bacteria

Related Publications

L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
January 1990, Texas Heart Institute journal,
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
April 1989, The Journal of antimicrobial chemotherapy,
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
September 1987, Antimicrobial agents and chemotherapy,
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
November 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
April 1977, Antimicrobial agents and chemotherapy,
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
March 1993, The Journal of antimicrobial chemotherapy,
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
December 1986, Presse medicale (Paris, France : 1983),
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
May 1987, Pathologie-biologie,
L Dubreuil, and M Derriennic, and A Reynaud, and J Devos, and C Romond, and A Courtieu
September 1980, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!